| Apoplexie | |
| — Cerebrale Durchblutungsstörungen | P104 , P316, P317, P318 |
| Arrhythmien | |
| — EKG | Z76 , H217, P461 |
| — Elektrophysiologie, klinisch-experimentell | Z80 , P91, P92, P365 |
| — Kammertachykardie u. -flimmern | P112 , P113, H168, H200, P292, P353, P360, P361, P440, P441, P463, P465 |
| — Katheterablation: supraventrikuläre Tachykardien | Z81 , P356, P444 |
| — Katheterablation: Techniken | P336 , P357, P358 |
| — Katheterablation: ventrikuläre Tachykardien | Z82 , P359 |
| — Katheterablation: Vorhofflattern/-flimmern | Z75 , P358, P362 |
| — Lokalisationsdiagnostik, Mapping | P360 , P364 |
| — Plötzlicher Herztod | Z76 , H203, P313, P431, P460, P461, P462 |
| — Supraventrikuläre Tachykardie, WPW-Syndrom | H168 |
| — Synkope | P299 , P462, H520, K555 |
| — Vorhofflimmern/-flattern | B57 , Z83, P90, P104, H167, H181, H182, P298, P330, P363, P364, P429, P430, P458, P464, P466, P467, P468 |
| Autonomes Nervensystem | |
| — Autonomes Nervensystem | Z80 , P89, P100, P365, K555 |
| Belastungsuntersuchungen | |
| — Herzinsuffizienz | H41 , P299 |
| — Klappenerkrankungen u. -missbildungen | P309 , P310 |
| — Koronare Herzerkrankungen | P449 , P450, P455, P459 |
| Computer in der Kardiologie | |
| — Datenbanken | H220 |
| — Digitale Bildverarbeitung | B67 , P490 |
| — Medizinische Entscheidungsfindung | P118 , H217, P335, P432, P459, P488, P489 |
| Diabetes mellitus | |
| — Diabetes und Herzinsuffizienz | H399 |
| — Diabetes und KHK | H399 |
| Echokardiographie | |
| — 3D-Rekonstruktion | P487 |
| — Echokardiographie: Belastung | P309 , P310 |
| — Echokardiographie: Doppler | H42 , B64, P307, P308, P480 |
| — Echokardiographie: Kontrastmittel | P295 , P479 |
| — Echokardiographie: M-Mode & 2D | P99 , H267, P445 |
| — Echokardiographie: Transösophageal | P486 , P487 |
| — Gewebedoppler | B59 , Z84, P111, P312, P315, P484 |
| EKG | |
| — Belastungs-EKG | P87 |
| — EKG-Mapping | P431 , P447, H513 |
| — Langzeit-EKG | P430 |
| — Spätpotentiale | P429 |
| Entzündliche und nichtentzündliche Erkrankungen de | |
| — Endokarditis | P301 , P443 |
| — Kardiomyopathie: allgemein | P482 |
| — Kardiomyopathie: hypertrophisch | B59 , P312, P313, P315, P483 |
| — Myokarditis | P123 |
| — Nichtinfektiöse Myokarderkrankungen | B66 , P121, P482 |
| Epidemiologie, Prävention und Rehabilitation | |
| — Arteriosklerose | B62 , P93, P94, P102, P476 |
| — Intervention | P117 , P468 |
| — Prävention | B58 , B71, P97, P100, P101, H504 |
| — Prognose | P95 , P98, P99, P125 |
| Gefäße | |
| — Angiogenese | P319 |
| — Arteriosklerose / Stenose | H40 , H45, B55, B70, P103, H267, P326, P327, H400, P492, P498 |
| — Durchblutung anderer Organe | P318 , P496 |
| — EDRF / NO / Nitrate | P323 , P324 |
| — Endothel-Biologie | H172 , P321, P322 |
| — Freie Radikale | B73 , P325 |
| — Koronardurchblutung | P320 |
| — Lipoproteine | P326 |
| — Molekularbiologie | B72 , P108 |
| — Vasoaktive Substanzen Mediatoren | P320 , H398 |
| — Wachstumsfaktoren | P316 , P317 |
| Herz- und Gefäßchirurgie | |
| — Angeborene Vitien | P303 |
| — Assistsysteme | P113 |
| — Klappenersatz, allgemein | H46 , P304 |
| — Koronararterien | P302 , P306 |
| — Myokardprotektion | P305 |
| Herzfunktion, Untersuchungsmethoden | |
| — Angiokardiographie, Methodik | B56 , P119, P493 |
| — Herzkatheterismus | B56 , H286, P493, P495 |
| — Radiologie | P454 , P456 |
| — Systolische u. diastolische Ventrikelfunktion | B60 , B69, Z84, P111, P311, P347, P439, P452, P479, P480, P481 |
| Herzinsuffizienz | |
| — Experimentell | P90 , P119 |
| — Myokardfunktion | H42 , P123, H408 |
| — Prognose | P300 , H520 |
| — Stoffwechsel | H173 |
| — Therapie | H36 , H41, Z78, P109, P110, P114, P115, P116, P117, P118, H181, H182, H192, H211, H273, P298, P303, P329, P348, P349, P350, P351, P352, P353, P354, P355, P432 |
| Herzklappenfehler | |
| — Aortenklappe | B64 , B68, P304, P307, P448, P457, P486 |
| — Klappenersatz | P105 |
| — Kongenitale Vitien im Erwachsenenalter | P308 |
| Herzschrittmacher | |
| — Antibradykarde Schrittmacher: bifokale Systeme: Technik, Elektroden | Z77 , Z78, P110, P116, P122, P331, P332, P333, P336, P337, P348 |
| — Bifokale Systeme: Klinik | P109 , P115, P329, P330, P338, P349 |
| — Frequenzadaptive Schrittmacher: Technik, Elektroden | Z79 , P328, P334 |
| — Frequenzadaptive Systeme: Klinik | Z79 , Z82, P328, P334, P335, P359, P485 |
| — Implantierb. Defibrillator: (Ventrikel): Elektroden | P350 , P351, P441 |
| — Implantierb. Defibrillator: (Ventrikel): Klinik | P112 , P114, P292, P439, P440, P442, P444, P445, P446 |
| — Implantierb. Defibrillator: (Ventrikel): Prognose | P464 |
| — Implantierb. Defibrillator: (Ventrikel): Technik | H220 , P352, P443, P447 |
| Hochdruck | |
| — Hämodynamik | P481 |
| — Mechanismen | P451 |
| Kardiologische Intensivmedizin | |
| — Kardiologische Intensivmedizin | P124 , H200, H203, H210, H408, P442, P469, P477 |
| Kardiovaskuläre Krankenpflege | |
| — Kardiovaskuläre Krankenpflege | H286 , P469 |
| Kinderkardiologie | |
| — Interventionen: Arrhythmien | Z81 , P122, P338, P356 |
| — Verlauf | P485 |
| Klinische Studien Methodik | |
| — Klinische Studien | B65 , P96, P120, P125, H173, H215, H274, P327, P331, P332, P333, P355, P361, P446, P470, P473 |
| — Methodik | P105 , P124 |
| Koronare Herzkrankheit | |
| — Instabile Angina pectoris | P339 , P344, H405 |
| — Koronardurchblutung, klinisch | B69 , P340, P347 |
| — Koronarmorphologie | H45 , H268, P294, P302 |
| — Myokardperfusion | P341 |
| — Quantitative Koronarangiographie | P491 |
| — Risikofaktoren / Prognose | B58 , B62, B71, P93, P94, P95, P96, P97, P98, P101, P102, P103, H274, P324, H398, P435, P436, P437, P476, P494, H502, H504, H508 |
| — Stabile Angina pectoris | Z77 , H270, P337, P343 |
| Koronargefäße, Interventionelle Verfahren, PTCA | |
| — Intravaskulärer Ultraschall bei Intervention | B67 , P293, P490 |
| — Neue Methoden | H47 , P106, P295, P296, P306, P433, P434, P488, P489 |
| — PTCA: Klinik u. Indikation | H270 , P339, P345, H405, P497 |
| — PTCA: Komplikation | P346 , P494 |
| — PTCA: Restenose | B70 , P498 |
| — PTCA: Technik | P294 , P297, P495 |
| — Stent: Indikation, Ergebnisse | P340 |
| — Stent: Restenose | B72 , P108, P343, P491 |
| Myokard | |
| — Genexpression | P300 |
| — Hibernation / Stunning / Preconditioning | B74 , P85 |
| — Hypertrophie / Wachstumsfaktoren | P87 , P88, P89 |
| — Inotropie / inotrope Substanzen | H36 |
| — Insuffizienz | H50 , P86, H192 |
| — Kardiomyopathie / Myokarderkrankungen | B60 , B66, Z83, P86, P121, H167, H273, P311, P314, P467, P483, P484 |
| — Reperfusion | P305 |
| — Stoffwechsel | P478 |
| Myokardinfarkt | |
| — Myokardinfarkt: akute Phase | H170 , P471, P473, P474, P477 |
| — Myokardinfarkt: interventionelle Kardiologie | H47 , H49, P345, P346, P470, P497 |
| — Myokardinfarkt: Mechanismen und Physiopathologie | B61 , B63, H172, P341, P342, P438, P453, P472 |
| — Myokardinfarkt: Postinfarktperiode | B74 , P85, H171 |
| — Myokardinfarkt: Prognose, Prävention | H215 , P471 |
| — Myokardinfarkt: Thrombolyse | P475 |
| — Myokardischämie | P465 |
| Neurohumorale Regulation | |
| — Neurohumorale Regulation | P88 , P354, P472 |
| Nuklearkardiologie und Bildgebung | |
| — Magnetresonanz | H49 , H50, B57, B61, B63, B65, B68, P120, P314, P342, P357, P438, P448, P449, P450, P451, P452, P453, P454, P455, P456, P457, P458 |
| — Myokardszintigraphie | P437 , P478 |
| — PET | P301 |
| — Ultraschnelle Computertomographie | H46 , H268, P296, P433, P434, P435, P436 |
| Periphere Gefäße | |
| — Laser: experimentell | P319 |
| — PTA | H40 , P293, P297, P496 |
| — Ultraschall | B55 , P107, P492 |
| Pharmakologie, Pharmakotherapie | |
| — Antiarrhythmika | P91 , P92 |
| — Antihypertensiva, allgemein | H211 |
| — Inotrope Substanzen | H170 |
| — Interaktion von Medikamenten | H210 , P344, H400, P463, H502 |
| — Nitrate | P321 , P322, P323 |
| — ß-Rezeptor-Agonisten u. -Antagonisten | B73 , H171, P325, H508 |
| Reizbildung und Erregungsleitung | |
| — Arrhythmien | P466 |
| — Elektrophysiologie | Z75 , P362, P363, H513 |
| — Stoffwechsel | P460 |
| Thrombose, Thrombozytenfunktion | |
| — Antikoagulation | P107 , P474 |
| — Blutgerinnung, experimentell | H48 |
| — Blutgerinnung, klinisch | H48 , P106 |
| — Thrombozytenaggregation |